| # | Drug | Count |
|---|---|---|
| 0 | PACLITAXEL | 7 |
| 1 | ADALIMUMAB | 6 |
| 2 | PREDNISONE | 6 |
| 3 | ATENOLOL | 5 |
| 4 | GLYBURIDE | 5 |
| 5 | PYRIDOSTIGMINE BROMIDE ORAL | 5 |
| 6 | AMLODIPINE | 4 |
| 7 | INSULIN GLARGINE | 4 |
| 8 | INSULIN GLARGINE-YFGN | 4 |
| 9 | PREDNISOLONE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PYRIDOSTIGMINE BROMIDE ORAL | 5 | 0.0014 |
| 1 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 2 | PEGFILGRASTIM | 3 | 0.0003 |
| 3 | IVERMECTIN | 1 | 0.0002 |
| 4 | GLYBURIDE | 5 | 0.0002 |
| 5 | INSULIN GLARGINE-YFGN | 4 | 0.0002 |
| 6 | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | 1 | 0.0001 |
| 7 | HEPARIN SODIUM | 2 | 0.0001 |
| 8 | MESNA INJECTION | 1 | 0.0001 |
| 9 | MESNA | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 12 |
| 1 | Microtubule Inhibitor [EPC] | 7 |
| 2 | Platinum-based Drug [EPC] | 6 |
| 3 | Sulfonylurea [EPC] | 5 |
| 4 | beta-Adrenergic Blocker [EPC] | 5 |
| 5 | Calcium Channel Blocker [EPC] | 4 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 4 |
| 7 | Insulin Analog [EPC] | 4 |
| 8 | Janus Kinase Inhibitor [EPC] | 4 |
| 9 | Alkylating Drug [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiparasitic [EPC] | 1 | 0.0002 |
| 1 | Pediculicide [EPC] | 1 | 0.0002 |
| 2 | Microtubule Inhibitor [EPC] | 7 | 0.0000 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Sulfonylurea [EPC] | 5 | 0.0000 |
| 7 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Janus Kinase Inhibitor [EPC] | 4 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 6 | 0.0000 |